NCT01578447View on ClinicalTrials.gov

Acceptability of Depo-subQ Provera 104 in Uniject vs. Intramuscular Depo-Provera Among HIV+ Women & Providers, Uganda

NACompletedINTERVENTIONAL

Enrollment

356

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions

Acceptability of Different Contraceptive Injection Types

Interventions

DRUG

DepoSubQ Provera 104 in Uniject

DRUG

Intramuscular DMPA

Trial Locations (1)

Unknown

Rakai Health Sciences Program, Kalisizo

All Listed Sponsors

collaborator

Society of Family Planning

OTHER

collaborator

Bill and Melinda Gates Foundation

OTHER

collaborator

Rakai Health Sciences Program

OTHER

lead

Johns Hopkins Bloomberg School of Public Health

OTHER

NCT01578447 - Acceptability of Depo-subQ Provera 104 in Uniject vs. Intramuscular Depo-Provera Among HIV+ Women & Providers, Uganda | Biotech Hunter | Biotech Hunter